William Blair Investment Management portfolio manager Jim Golan joined TD Ameritrade Network’s Morning Trade Live to discuss the tech securities drawing attention in the midst of earnings season.

Investment Management
William Blair Investment Management portfolio manager Jim Golan joined TD Ameritrade Network’s Morning Trade Live to discuss the tech securities drawing attention in the midst of earnings season.
Stay up-to-date with the latest William Blair news and insights
William Blair acted as exclusive financial advisor to Brightflag, a portfolio company of One Peak Partners, Sands Capital, Frontline Ventures, Tribal Ventures, and Enterprise Ireland, in connection with its pending sale to Wolters Kluwer (EURONEXT: WKL) for €425 million.
William Blair initiated research coverage of Ultragenyx Pharmaceutical Inc. (RARE $35.66), a commercial-stage, modality-agnostic biotechnology company specializing in developing therapies for the treatment of rare and ultrarare genetic diseases.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures